Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Abnormal ECA-Binding Membrane Glycans and Galactosylated CAT and P4HB in Lesion Tissues as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis. | Front Oncol | 2022 | 35392238 | PubTator, text mining | PubMed |
| Bidirectional regulation of desmosome hyperadhesion by keratin isotypes and desmosomal components. | Cell Mol Life Sci | 2022 | 35380280 | PubTator, text mining | PubMed |
| IL-4/IL-13 Axis in Allergic Rhinitis: Elevated Serum Cytokines Levels and Inverse Association With Tight Junction Molecules Expression. | Front Mol Biosci | 2022 | 35372516 | PubTator, text mining | PubMed |
| The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With Rituximab. | Front Immunol | 2022 | 35371083 | PubTator, text mining | PubMed |
| Lactobacillus paracasei BD5115-Derived 2-Hydroxy-3-Methylbutyric Acid Promotes Intestinal Epithelial Cells Proliferation by Upregulating the MYC Signaling Pathway. | Front Nutr | 2022 | 35369066 | PubTator, text mining | PubMed |
| Allele frequency and the associations of HLA-DRB1 and HLA-DQB1 polymorphisms with pemphigus subtypes and disease severity. | Medicine (Baltimore) | 2022 | 35363186 | PubTator, text mining | PubMed |
| Retrospective study of gingival involvement in pemphigus: A difficult to treat phenomenon. | Dermatol Ther | 2022 | 35352853 | PubTator, text mining | PubMed |
| Pemphigus herpetiformis in a 4-year-old child: Case report and review of the literature. | Clin Case Rep | 2022 | 35340647 | PubTator, text mining | PubMed |
| Marked to Die-Cell Death Mechanisms for Keratinocyte Acantholysis in Pemphigus Diseases. | Life (Basel) | 2022 | 35330080 | PubTator, text mining | PubMed |
| The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management. | Int J Mol Sci | 2022 | 35328669 | PubTator, text mining | PubMed |
| Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? | Cells | 2022 | 35326398 | PubTator, text mining | PubMed |
| Functional investigation of two simultaneous or separately segregating DSP variants within a single family supports the theory of a dose-dependent disease severity. | Exp Dermatol | 2022 | 35325485 | PubTator, text mining | PubMed |
| Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris. | Acta Derm Venereol | 2022 | 35312020 | PubTator, text mining | PubMed |
| Varicella Zoster With Pemphigus-like Reaction. | Am J Dermatopathol | 2022 | 35311755 | PubTator, text mining | PubMed |
| Discovering Novel Biomarkers Associated with the Pathogenesis of Psoriasis: Evidence from Bioinformatic Analysis. | Int J Gen Med | 2022 | 35300136 | PubTator, text mining | PubMed |
| Severe visceral leishmaniasis and COVID-19 coinfection in an immunosuppressed patient. | Rev Inst Med Trop Sao Paulo | 2022 | 35293559 | PubTator, text mining | PubMed |
| Immunopathology and Immunotherapy of Inflammatory Skin Diseases. | Immune Netw | 2022 | 35291649 | PubTator, text mining | PubMed |
| Inhibition of retinoid X receptor improved the morphology, localization of desmosomal proteins and paracellular permeability in three-dimensional cultures of mouse keratinocytes. | Microscopy (Oxf) | 2022 | 35289919 | PubTator, text mining | PubMed |
| Effectiveness of topical pilocarpine in refractory oral lesions of pemphigus vulgaris: Results from an open-label, prospective, pilot study. | Dermatol Ther | 2022 | 35289044 | PubTator, text mining | PubMed |
| Some Good and Some Bad: Sand Fly Salivary Proteins in the Control of Leishmaniasis and in Autoimmunity. | Front Cell Infect Microbiol | 2022 | 35281450 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=39